Ozempic and Wegovy users who have suffered blindness, vomiting and even the loss of a loved one have warned about the 'dark ...

Alcohol and Weight Loss Medications This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA It’s normal to have lots ...

Scientists are taking a closer look at the pill forms of Wegovy and Ozempic. In an animal study, the ingredient SNAC, which helps semaglutide survive the stomach and enter the bloodstream, was ...

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

Novo Nordisk said Wednesday it will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said the FDA has approved ...

Eye strokes’ that reduce blood flow to optic nerve likely to be side-effect of active ingredient semaglutide, says author ...

Novo Nordisk (NVO) on Wednesday announced plans to launch some doses of its oral GLP-1 receptor agonist semaglutide under the brand name Ozempic pill in Q2 2026, following a successful commercial ...

Wegovy, a GLP-1 agonist for weight loss, may carry the highest risk of "eye stroke" (ischemic optic neuropathy) and sudden sight loss of the semaglutide drugs, finds an analysis of unintended side ...

Medically reviewed by Lindsay Cook, PharmDKey TakeawaysBoth Rybelsus and Ozempic contain semaglutide and help control blood sugar and aid in weight loss.Both drugs are used to treat type 2 diabetes, ...

Novo Nordisk A/S (NYSE:NVO) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 9, Novo Nordisk A/S (NYSE:NVO) announced its partnership with Hims & Hers. The deal ...

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. REUTERS/Tom Little Feb 4 (Reuters) - Novo Nordisk said on ...